Buy Donepezil
Donepezil

0.7
A medication that helps slow down the progression of symptoms in Alzheimer's disease.


Ingredient
Category
Availability
In Stock
Delivery
Airmail (14-21 days) | EMS trackable (5-9 days)
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Product Sheet

Alternative/Local Brand
Aricept
Active Ingredient(s)
Donepezil
Primary Category
Dementia treatment, Alzheimer's care
Therapeutic Class
Anti-dementia drugs, Anticholinesterases
Pharmacological Class
Cholinesterase inhibitors
Indications
Mild to moderate Alzheimer's disease, Mixed dementia
Contraindications
Hypersensitivity to piperidine derivatives, Pregnancy
Minor Side Effects
Diarrhoea, Nausea, Insomnia
Moderate Side Effects
Cramps, Fatigue, Loss of appetite
Serious Side Effects
Fainting, Slow heart rate, Gastrointestinal bleeding, Seizures
Dosage Forms
Tablets, Orally disintegrating tablets
Administration Route
Oral
Mechanism of Action
Donepezil prevents the breakdown of acetylcholine, a chemical in the brain involved in memory and thinking. By increasing levels of this messenger, it can help improve or stabilize cognitive function and daily tasks.
Prescription Status
Rx
Patient Summary
A medication that helps slow down the progression of symptoms in Alzheimer's disease.
Onset Time
3-4 weeks
Duration
24 hours
Storage Instructions
Store at room temperature.
Drug Interactions
NSAIDs, Anticholinergics, Beta-blockers
Age Restrictions
Adults/Elderly
Pregnancy Use
Not recommended.
Alternative Drugs
Rivastigmine, Galantamine

Donepezil: Generic Medication Overview

This article covers Donepezil, available as a generic medication and marketed under brand names such as Aricept. Donepezil belongs to the neurology therapeutic class and is supplied as a pill in strengths of 5 mg and 10 mg. In Hong Kong, it is a prescription-only product regulated by the Department of Health’s Drug Office.

How Donepezil Works in the Body

Donepezil is an acetylcholinesterase inhibitor. By blocking the enzyme acetylcholinesterase, it slows the breakdown of acetylcholine-a neurotransmitter critical for memory and cognition. Higher acetylcholine levels help improve communication between nerve cells in brain regions that are affected early in Alzheimer’s disease.

  • Onset of action: Clinical effects may be noticed within 2 weeks, with maximal benefit usually seen after several months of consistent use.
  • Duration: The drug’s half-life is approximately 70 hours, allowing once-daily dosing.
  • Metabolism: Donepezil is metabolised primarily by hepatic cytochrome P450 enzymes CYP2D6 and CYP3A4, then excreted in urine and feces.

Conditions Treated by Donepezil

Approved Medical Uses

  • Alzheimer’s disease (mild to moderate) - Approved by the US FDA, European EMA, and Hong Kong’s Drug Office for symptomatic treatment of cognitive decline.
  • Alzheimer’s disease (severe) - The 10 mg dose is indicated for patients whose disease has progressed despite the lower dose.

These approvals are based on clinical trials showing modest improvements in global cognition, daily functioning, and behavior compared with placebo.

Off-Label and Investigational Applications

  • Lewy body dementia - Some clinical guidelines suggest Donepezil may improve cognitive symptoms, although it is not formally approved for this indication.
  • Parkinson’s disease dementia - Evidence from small-scale studies indicates potential benefit, but regulatory approval is lacking.

Disclaimer: Off-label use requires medical supervision and individualized risk assessment.

Who Should (Not) Use Donepezil?

Ideal Patient Profile

  • Adults diagnosed with mild, moderate, or severe Alzheimer’s disease.
  • Patients who can adhere to a once-daily oral regimen.

Absolute Contraindications

  • Known hypersensitivity to Donepezil or any of its excipients.
  • Current use of non-selective cholinergic antagonists (e.g., atropine) that would negate therapeutic effect.

Relative Contraindications

  • Cardiac conduction abnormalities (e.g., sick sinus syndrome, second- or third-degree AV block) - Donepezil may exacerbate bradyarrhythmias.
  • Severe hepatic impairment - Reduced metabolism may increase drug exposure.
  • Renal impairment - Dose adjustment may be needed in end-stage renal disease.
  • Pregnancy and lactation - Classified as Pregnancy Category C; benefits must outweigh potential fetal risks.

Special Populations

  • Elderly patients - Start at the lower dose (5 mg) and monitor for bradycardia, dizziness, and falls.
  • Patients on anticholinergic medicines (e.g., certain antihistamines, bladder antispasmodics) - May experience reduced efficacy of Donepezil.

If any of these conditions apply, a healthcare professional should evaluate the risk-benefit balance.

Safety Profile: Side Effects and Interactions

Common Side Effects

  • Nausea - Often transient, may improve with food.
  • Diarrhoea - Usually mild; maintain hydration.
  • Insomnia - Take the dose in the morning if sleep disturbances occur.
  • Muscle cramps - May be relieved by gentle stretching.

Serious Adverse Events

  • Bradycardia - Rare but may require medical attention, especially in patients with pre-existing cardiac disease.
  • Syncope - Consider evaluation for underlying arrhythmia.
  • Severe gastrointestinal bleeding - Observed when combined with NSAIDs or anticoagulants.

Drug Interactions

  • CYP2D6 or CYP3A4 inhibitors (e.g., fluoxetine, ketoconazole) - May increase Donepezil plasma levels; monitor for toxicity.
  • Anticholinergic agents - Reduce Donepezil’s cognitive benefits; dose adjustments or alternative therapies may be needed.
  • Beta-blockers - Additive effects on heart rate; cardiac monitoring advised.
  • NSAIDs/anticoagulants - Heightened risk of GI bleeding; consider gastro-protective strategies.

Food and Lifestyle Interactions

  • Food: Can be taken with or without meals; consistent timing improves adherence.
  • Alcohol: No direct contraindication, but excessive intake may worsen dizziness or GI upset.
  • Driving: Caution if experiencing dizziness, visual disturbances, or severe fatigue.

Patients should disclose all prescription, over-the-counter, herbal, and dietary supplements before initiating Donepezil.

How to Take Donepezil

  • Standard dosing:
  • Start with 5 mg pill once daily, preferably in the evening.
  • After 4-6 weeks, if tolerated and clinical response is inadequate, the dose may be increased to 10 mg once daily.
  • Administration: Swallow the tablet whole with a glass of water; do not crush or chew.
  • Missed dose: Take the missed dose as soon as remembered unless it is near the time of the next scheduled dose. Do not double the dose.
  • Overdose: Symptoms may include extreme nausea, vomiting, diarrhoea, and severe bradycardia. Seek emergency medical care; supportive measures are the mainstay of treatment.
  • Discontinuation: Abrupt cessation can lead to a rapid decline in cognition. A gradual taper is advisable under physician guidance.

Dose adjustments may be required for patients with severe hepatic or renal impairment; the prescribing clinician will determine the appropriate regimen.

Monitoring and Follow-Up

  • Baseline assessment: Cognitive testing (e.g., MMSE), vital signs, ECG (if cardiac risk factors present).
  • Follow-up visits: Every 3-6 months to evaluate cognitive response, side-effect profile, and adherence.
  • Laboratory tests: Not routinely required, but liver function tests may be ordered in patients with hepatic disease.
  • When to contact a provider: New or worsening bradycardia, syncope, severe GI bleeding, persistent nausea, or any unexpected symptom.

Regular monitoring helps optimise therapeutic benefit while minimising adverse effects.

Storage and Handling

  • Store Donepezil tablets at room temperature (20-25 °C), away from moisture and direct sunlight.
  • Keep the container tightly closed and out of reach of children.
  • Do not use the medication after the expiration date printed on the label.
  • For disposal, follow local guidelines for medication take-back programs or return to a pharmacy.

Medication-Specific Glossary

Acetylcholinesterase Inhibitor
A class of drugs that block the enzyme acetylcholinesterase, thereby increasing acetylcholine levels in the brain.
Half-Life
The time required for the plasma concentration of a drug to reduce by half; for Donepezil, approximately 70 hours.
CYP2D6 / CYP3A4
Liver enzymes involved in the metabolism of many medications, including Donepezil; inhibitors of these enzymes can raise drug levels.

Medical Disclaimer

This article provides educational information about Donepezil and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.

Donepezil FAQ

Can Donepezil be taken with food or on an empty stomach?

Donepezil can be administered with or without food. Consistency in timing helps maintain stable drug levels, but taking it with a light snack may reduce mild gastrointestinal upset in some patients.

What should I do if I miss a dose of Donepezil?

Take the missed dose as soon as you remember, unless it is almost time for the next scheduled dose. In that case, skip the missed dose and continue with the regular dosing schedule. Do not double the dose.

Does Donepezil interact with common over-the-counter pain relievers?

Yes. Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen can increase the risk of gastrointestinal bleeding when combined with Donepezil. Use the lowest effective NSAID dose and consider gastro-protective agents if long-term use is needed.

Is Donepezil safe for people with heart rhythm problems?

Donepezil can cause bradycardia and may exacerbate existing conduction abnormalities. Patients with sick-sinus syndrome, AV block, or a history of fainting should have cardiac evaluation before starting therapy.

Can I travel internationally with Donepezil?

Donepezil is a prescription-only medication in Hong Kong and most countries. Carry the original prescription label, a copy of the prescription, and a letter from your physician if possible. Keep the medication in its original packaging to avoid customs issues.

Do I need to avoid alcohol while taking Donepezil?

Moderate alcohol consumption is generally permissible, but excessive drinking may worsen dizziness, nausea, or other side effects. Use caution and monitor how your body responds.

How long does it take to see cognitive improvement after starting Donepezil?

Clinical improvements may become noticeable after 2 weeks, but the full therapeutic effect often emerges after 3-6 months of consistent use. Ongoing assessment is essential to gauge benefit.

Are there any visual side effects associated with Donepezil?

Some patients report blurred vision or difficulty focusing, especially when first starting the medication. If visual disturbances persist, discuss them with your healthcare provider.

What is the difference between the 5 mg and 10 mg tablets?

Both tablets contain the same active ingredient, Donepezil, but the 10 mg tablet delivers a higher dose. The 5 mg dose is typically used to start therapy, with the 10 mg dose considered after several weeks if tolerated and needed for greater symptom control.

Is Donepezil covered by Hong Kong’s public health insurance?

Coverage varies by individual plan and eligibility criteria. Patients should consult the Hospital Authority or private insurers for specific information regarding reimbursement or subsidy options.

Categories